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This study aimed to explore if natural dizygotic (DZ) twinning is associated with earlier menopause and
lower anti-Mullerian hormone (AMH) values. We investigated if advanced biological reproductive aging,
which can be responsible for the multiple follicle growth in familial twinning, is similar to mechanisms that
occur in normal ovarian aging, reflected by earlier menopause in mothers of DZ twins and lower levels of
AMH. A total of 16 mothers of DZ twins enrolled with the Netherlands Twin Register (average age at first
assessment: 35.9 ± 3.0 years) and 14 control mothers (35.1 ± 3 years) took part in a prospective study.
Fifteen years after entry into the study, which included follicle-stimulating hormone (FSH) assessment,
AMH was measured in stored serum samples and menopause status was evaluated. Average AMH levels
were not significantly different between DZ twin mothers and controls (2.1 ± 2.4 g/L vs. 1.9 ± 1.9 g/L).
Among the 16 mothers of twins, 7 had an elevated (FSH) value over 10 U/L at first assessment. Their
AMH levels were lower than the nine twin mothers with normal FSH values: 0.6 ± 0.4 versus 3.4 ± 2.6
g/L (p = .01). Of the mothers of twins, eight mothers had entered menopause at the second assessment
compared with only one control mother (p = .07). Thus, slightly more DZ mothers were in menopause than
the control mothers, although this difference was not significant. The subgroup of DZ twin mothers who
had an increased FSH concentration 15 years ago had a limited ovarian reserve as reflected by lower AMH
levels. These data indicate that advanced ovarian aging can be a feature in familial DZ twinning, particularly
with elevated early follicular phase FSH.
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Dizygotic (DZ) twinning is a consequence of multiple fol-
licle growth (Martin et al., 1991a), subsequent multiple
ovulation, and fertilization ofmultiple oocytes. Known risk
factors for natural dizygotic twinning include heredity, ge-
netic predisposition, advanced maternal age, and maternal
characteristics suchas increasedheight andbodymass index
(BMI; Hoekstra et al., 2008, 2010; Lichtenstein et al., 1996;
Parisi et al., 1983) In singleton pregnancies, one dominant
follicle is selected when the follicle-stimulating hormone
(FSH) level reaches a certain threshold (Schoemaker et al.,
1993). However, if FSH levels exceed this threshold for too
long, multiple follicles can be selected, thereby creating a
risk for multiple pregnancies. Multiple follicular develop-
ment in several cycles has been shown in mothers of dizy-
gotic twins (Martin et al., 1991a). High FSH levels in the
early follicular phase can also indicate a decreased ovarian
reserve (Lambalk et al., 2009) associated with reproductive
aging. Advancedmaternal age is associated withmore natu-
ral DZ twinning probably due to these increased FSH levels
(Beemsterboer et al., 2006; Bulmer, 1979). In mothers of
DZ twins who come from families with multiple twins, ele-
vated FSH in the early follicular phase is also a characteristic
feature (Lambalk et al., 1998b;Martin et al., 1991b; Thomas
et al., 1998). In general, with familial dizygotic twinning, no
clear indication for advanced ovarian aging has been found
(Gilfillan et al., 1996), although it has been hypothesized
that familial twinning may occur via a hereditary mecha-
nism similar to that of advanced ovarian aging (te Velde
et al., 1998), which could imply that DZ twinning is
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associated with earlier menopause. So advanced biological
aging may be responsible for the multiple follicle growth
in familial twinning along mechanisms identical to that in
normally aging women (Lambalk et al., 2009).
In a previous study, we found increased levels and pul-
satility of FSH in mothers with familial dizygotic twinning
but no clear signs of limited ovarian feedback (Lambalk
et al., 1998a, 1998b). Recently, another hormone secreted
by small non-developing follicles has been indicated as a
good and subtler estimate for ovarian aging, namely anti-
Mullerian hormone (AMH). Low or undetectable levels are
associated with biologically ovaries of advanced age and
menopause (Broer et al., 2011; Tehrani et al., 2009; van Dis-
seldorp et al., 2008;Visser et al., 2006). Fifteen years after the
first study, we aimed to measure AMH in the stored blood
samples from the original participants (Lambalk et al.,
1998b). Second, the occurrence of early menopause in the
original cohort of mothers of DZ twins and their aged-
matched controls was assessed by self-report, in order to
test the hypothesis that having had a DZ pregnancy is asso-
ciated with a lower ovarian reserve reflected by lower AMH
levels and the occurrence of menopause at an earlier age.
Subjects and Methods
Subjects
The study, conducted in 1998, included 16 mothers of DZ
twins with a family history of twinning and 14 control
mothers (Lambalk et al., 1998b). Mothers of DZ twins were
recruited through the annual newsletter of the Netherlands
TwinRegister (Boomsmaet al., 2006; Lambalk et al., 1998b).
Inclusion criteriawere spontaneousbirthofDZ twins of un-
equal sex (to establish zygosity) before age of 36, at least one
other DZ twin pair in a first or second degree female rela-
tive, good general health, no medical treatment at the time
of the study, and no hormonal treatment 6 months prior to
the study advent. Inclusion criteria for the singleton control
mothers were good general health, no medical treatment at
the time of the study, no hormonal treatment 6months pre-
ceding the study, having givenbirth to at least two singletons
before the age of 36, and no history of familial twinning. Fif-
teen years later we approached the study population with
a small survey consisting of items about general medical
history and obstetric/gynaecological history (de Boer et al.,
2002). BMI was based on self-reported height and weight.
Women who had undergone a hysterectomy (N = 4) or
who were currently using oral hormonal contraception or
a Mirena intrauterine device (N = 2) were excluded from
follow-up analysis as menopausal status could not be deter-
mined. Informed consent was provided by all participants
and the study was approved by the institutional scientific
review board and ethical committee.
Blood Sampling and Storage
For the first assessment, all women provided blood sam-
ples on cycle day 3. They kept a basal body temperature
chart to verify time of ovulation. FSH and luteinizing hor-
mone (LH) samplingwas done between 8:00 and 9:00 in the
morning. Blood samples were stored at −20◦C (Lambalk
et al., 1998b). In 2009,AMHwasmeasured in these samples.
Laboratory Essays
In 1998, LH and FSH were measured by means of a double
first monoclonal and second polyclonal antibody immuno-
radiometric assay (IRMA-mat BYK-Sangtec Diagnostica
GmBH & Co., Dietzenbach, Germany) with a lower detec-
tion limit of 0.2 IU/L. References for expression of LH and
FSH were first international reference preparations 68/40
and second international reference preparations 78/549,
respectively. LH intra-assay coefficients of variation (CV)
were 4.3% and 2.4% at the levels of # U/L and 23 U/L, re-
spectively. FSH intra-assay CVs were 3% and 1.8% at levels
7 and 74 U/L, respectively. Inter-assay CVs were below 8%
for both gonadotropins. For each individual, both hormone
values were measured in the same assay.
Inhibin A and B were measured in duplicate with two-
site, enzyme-linked immunoassays (Serotec, Oxford, UK;
Groome et al., 1994, 1996). CVs were less than 5% within
a plate and less than 7% between plates of both assays. The
sensitivity was 3 pg/mL for Inhibin A and 15 pg/mL for
Inhibin B.
Estradiol (E2) was measured in the previous study via
radioimmunoassay (Sorin Biomedical, Silage, Italy) with a
lower limit detection of 18 pmol/L and CVs of less than 5%.
For the current report, AMH was measured once given
its small intercycle variation. Serum AMH levels were mea-
sured by an ultrasensitive enzyme-linked immunosorbent
assay (Immunotech-Coulter, Marseilles, France), as de-
scribed elsewhere (Long et al., 2000). The limit of detection
(defined as negative control +3 SD of the negative control)
was 0.05 g/L. For positive quality control, high and low
serum samples from separate assays were used. For nega-
tive quality control, samples from postmenopausal women
were used. Intra- and inter-assay coefficients of variation
were <5% and 8%, respectively.
Statistical Analysis
Maternal menopausal age, subject’s menopausal status and
menopausal age (if applicable), tobacco use, parity, data on
gynecological surgery, menstrual cycle characteristics (past
and present), and current and past hormonal treatment
were compared between DZ twin mothers (cases) and age-
matched singletonmothers (controls) using Student’s t tests
for continuous data and 2 tests for dichotomous outcome
variables. For AMH levels, a cut-off of 0.5 g/L was used
(cut-off value for 95% of all values measured in controls).
Mean hormone concentrations were compared using a Stu-
dent’s t test. Pearson’s correlations were calculated between
AMHandFSH.Datawere analyzed in the Statistical Package
for the Social Sciences (SPSS) 15.
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TABLE 1
Characteristics (Mean ± SD) of Premenopausal Mothers of
Dizygotic Twins and Controls (12) at Baseline (in 1998)
Controls Twin mothers
Characteristics (n = 14) (n = 16) p
Age (year) 35.1 ± 3 35.9 ± 3.4 .5
Body mass index (kg/m2) 22.2 ± 3.9 23.0 ± 2.8 .511
Cycle length (days) 28.4 ± 2.7 26.4 ±2.2 .037
Smoking (packyears) 3.3 ± 5.6 7.0 ± 8.9 .051
Days from last delivery 1857 ± 1300 1615 ± 1153 .597
Parity 2.2 ± 0.4 1.9 ± 0.9 .351
Age at twin delivery – 30.0 ± 5.2 –
TABLE 2
Reproductive Hormones on Cycle Day 3 in Familial DZ Mothers
and Controls
Controls (n = 14) Twin mothers (n = 16) p∗
FSH (U/L) 6.0 ± 3.0 9.8 ± 5.5 .023
E2 (pmol/L) 140.0 ± 82.0 192.4 ± 170.4 .221
Inhibin A (pg/mL) 4.6 ± 3.7 3.8 ± 3.0 .549
Inhibin B (pg/mL) 77.8 ± 42.5 75.9 ± 45.8 .656
AMH (g/L) 1.9 ± 1.9 2.1 ± 2.4 .252
Note: AMH = anti-Mullerian hormone; E2 = Estradiol; FSH = follicle-
stimulating hormone.
∗Presented data and the statistical evaluation of FSH, E2, and the in-
hibins were taken from the original publication (Lambalk et al., 1998b).
Results
Baseline characteristics of the cohort are summarized in
Table 1 and AMH levels in Table 2. Mothers of DZ twins
(cases) had a shorter menstrual cycle and tended to smoke
more. On average there was no difference in AMH levels
between cases and controls, whereas FSH was significantly
higher in cases.
Table 2 also summarizes the early follicular phase values
of FSH, E2, InhibinA, and Inhibin B, ofwhich only FSHwas
significantly higher. Seven out of the 16 twin mothers had
an elevated FSH level (above 10 IU/L) in the early follicular
phase versus 1 out of 14 controls (p < .05). Within the
group of twinmothers, AMHwas substantially lower in the
mothers with elevated FSH levels. The twin mothers with
normal FSH also had AMH levels in the normal range. In
the twin mothers with elevated FSH levels, Inhibin A and
Inhibin B tended to be lower (p = .08), whereas there were
no differences in E2 levels (Table 3).
From the original group of 16 DZ twin mothers, 15 re-
sponded to the second assessment. From the 14 controls,
12 returned the survey. Results for menopause data in cases
and controls are summarized in Table 4. The average age at
time of response was around 50 years and was not signifi-
cantly different between cases and controls (50.9 ± 3.4 for
cases and 50.8 ± 3.36 for controls p = .9). Two twin moth-
ers could not provide usable information with regard to age
at menopause; both had undergone a hysterectomy around
the age of 40 for benign pathology. In the control group, five
women could not provide usable data onmenopause status.
TABLE 3
Cycle Day 3 Hormones in Mothers of Twins (n = 16) With
Normal or Elevated FSH
FSH < 10 FSH > 10
U/L (n = 9) U/L (n = 7) p
FSH (U/L) 6.1 ± 2.1 14.6 ± 5.0 .025
E2 (pmol/L) 194.0 ± 110.0 190.0 ± 237.0 1.0
Inhibin A (pg/mL) 5.0 ± 2.9 2.3 ± 2.7 .08
Inhibin B (pg/mL) 92.8 ± 49.0 54.3 ± 32.6 .08
AMH (g/L) 3.4 ± 2.6 0.6 ± 0.4 .01
Note: AMH = anti-Mullerian hormone; E2 = Estradiol; FSH = follicle-
stimulating hormone.
Two underwent a hysterectomy for benign pathology, two
were undergoing hormonal treatment for menstrual cycle
disturbances, and one mother had experienced menopause
after having undergone chemotherapy for breast cancer.
More than half of the twin mothers were postmenopausal
versus only one mother in the control group (p = .07).
Of the eight twin mothers for whom postmenopausal sta-
tus could be determined, those who had an elevated basal
FSH above 10 IU/L (n = 4) in the past, age of menopause
was 48.25 years. Age of menopause for the other four twin
mothers with normal basal FSH in the past was 50.25 years.
Discussion
We observed a trend that more mothers with familial DZ
twins had reached menopause compared with controls, al-
though this was not significantly different (p = .07) be-
tween the two groups in our small sample. However, AMH,
a novel marker for ovarian aging, was not lower despite
the prominently higher early follicular phase FSH values in
the total group of twin mothers (Lambalk et al., 1998b).
On the other hand, the subgroup of DZ twin mothers who
had an increased FSH concentration 15 years ago shows a
limited ovarian reserve as reflected by significantly lower
AMH levels. These mothers tended to have menopause
slightly earlier, namely at 48.25 years compared with the
50.25 years of those mothers with normal FSH. However,
none of the twin mothers had premature menopause (<40
years) or earlymenopause (<45 years).Noneof themothers
who had AMH levels that were too low to be detected had
menopause before the age of 48 years. Those twin mothers
who did not have an elevated FSH level showed levels of
AMH in the normal range. Together, our data point to the
fact that advancing of ovarian aging can be a feature in a
substantial number of situations of familial DZ twinning,
in particular when elevated early follicular phase FSH is
involved. But on the other hand, in many other twin moth-
ers, no signs of ovarian aging such as higher FSH or lower
AMH were present, indicating that the familial twinning
trait remains multi-causal.
There is substantial evidence that age at meno-
pause is genetically determined (Galloway et al., 2002;
Montgomery et al., 2004; Moore et al., 2004; Palmer et al.,
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TABLE 4
Menopause Data of Mothers of Dizygotic Twins and Controls
Controls (n = 12) Twin mothers (n = 15) p
Age (year) 50.4 ± 3.0 51.1 ± 4.0 .57
Evaluable mothers 7 13 –
Postmenopausal status 1 (14%) 8 (67%) .07
Age at menopause (if applicable, year) 50 Elevated FSH (N = 8) 48.2 –
Normal FSH (N = 4) 50.2
Not evaluable due to hysterectomy 2 2 –
Not evaluable due to use of hormonal treatment 2 0 –
Not evaluable due to chemotherapy 1 0 –
Note: Note: FSH = follicle-stimulating hormone.
2006; Stolk et al., 2012; Vink & Boomsma, 2005; Wyshak
& White, 1965). Therefore, it is not unlikely that to some
extent, genetic factors that are linked to female reproduc-
tive aging will be linked to familial DZ twinning. For ex-
ample, follicular growth, maturation, and ovulation are
tightly regulated via various pathways. One of these path-
ways is the transforming growth factor  (TGF) signaling
pathway. The oocyte secretes various substances to con-
trol growth and ovulation rates, which include the growth
differentiation factor-9 (GDF9) and bone morphogenetic
protein-15 (BMP15). Mutations in BMP15 and GDF9 have
been associated with increased DZ twinning and ovar-
ian depletion in sheep (Galloway et al., 2002; Hanrahan
et al., 2004). Remarkably, GDF9 mutation is also associ-
atedwith increased twinning rates inhumans (Montgomery
et al., 2004; Moore et al., 2004; Palmer et al., 2006).
The mechanism by which the FSH is elevated in nor-
mal ovarian aging is seemingly also present in familial DZ
twinning. When FSH is elevated, this is due to the presence
of fewer follicles in the aging ovaries, leading to a reduced
negative feedback via Inhibin B and estradiol (Lambalk
et al., 1998b). Decreased inhibin levels cause a reduced sup-
pression of FSH secretion (Lambalk et al., 2009). This al-
lows multiple follicle growth, which is a prerequisite for DZ
twinning. Older women indeed show spontaneous multi-
ple follicle growth in up to 25% of cycles whereas this is
only 5% in cycles of younger women (Beemsterboer et al.,
2006). This seems paradoxical to their prominent decline
in fertility. The risk of women over age 35 having DZ twins
is twice that of women under 25. This overshoot of FSH
may stimulate growth of multiple follicles. The risk factor
for twinning probably lies in the sharp decrease in number
of available follicles every month in older women and in
the accompanying increase in chromosomal abnormalities
in these oocytes, which are rendered non-viable. Overall,
fewer pregnancies will occur, but occasionally two or more
follicles with good quality oocytes are selected and somulti-
ple pregnancy occurs (Lambalk, 2001). In summary, many
mothers of DZ twins show subtle signs of limited ovarian
reserve, as indicated by hormone values. Therefore, ovarian
aging may play a role with familial DZ twinning and conse-
quently genetic features responsible for ovarian aging and
earlier ovarian aging could also attribute to the heredity of
DZ twinning in younger women. The fact that a number of
DZ twinmothers showed no sign of limited ovarian reserve
contributes to the notion that it is a trait of complex nature.
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